You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immunogenicity and safety of vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunogenicity of BNT162b2 Covid-19 Vaccine in Elderly People

Completed
  • Immunogenicity, Vaccine
    • Thessaloníki, Thessaloniki, Greece
      G. Gennimatas General Hospital
    Aug 3, 2022

    COVID-19, Influenza, Vaccine Reaction Trial in Seoul, Incheon (Omicron-containing COVID-19 vaccine, influenza vaccine)

    Recruiting
    • COVID-19
    • +3 more
    • Omicron-containing COVID-19 vaccine
    • influenza vaccine
    • Seoul, Guro-gu, Korea, Republic of
    • +1 more
    Oct 17, 2023

    Safety of a Single Dose of COMVIGEN Vaccine, Reactogenicity of a Single Dose of COMVIGEN Vaccine, Immunogenicity of a Single

    Not yet recruiting
    • Safety of a Single Dose of COMVIGEN Vaccine
    • +5 more
    • Comvigen (Bivalent, ChulaCov19 BNA159.2)
    • BIVALENT Pfizer/BNT vaccine
    • Bangkok, Thailand
    • +1 more
    Jun 29, 2023

    Tetanus Trial in Shangqiu (Investigational tetanus vaccine, adsorbed, Control tetanus vaccine, adsorbed)

    Recruiting
    • Tetanus
    • Investigational tetanus vaccine, adsorbed
    • Control tetanus vaccine, adsorbed
    • Shangqiu, Henan, China
      Liangyuan District Center for Disease Control and Prevention
    Sep 15, 2023

    Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

    Not yet recruiting
    • Influenza, Human
    • sa-mRNA vaccine Dose 1
    • +4 more
    • (no location specified)
    Sep 7, 2023

    SARS-CoV-2 Infection Trial in Hangzhou (Placebo, COVID-19 Vaccine (Vero Cell) ,Inactivated, COVID-19 mRNA Vaccine (ZSVG-02-O) 10

    Recruiting
    • SARS-CoV-2 Infection
    • Placebo
    • +4 more
    • Hangzhou, Zhejiang, China
      Shulan (Hangzhou) Hospital
    Nov 7, 2023

    Influenza Trial in Bangkok (TetraFluvac TF vaccine, Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023)

    Not yet recruiting
    • Influenza
    • TetraFluvac TF vaccine
    • Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023
    • Bangkok, Thailand
      Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
    May 30, 2023

    Polio Trial (polio vaccines: nOPV2, bOPV, IPV)

    Not yet recruiting
    • Polio
    • polio vaccines: nOPV2, bOPV, IPV
    • (no location specified)
    Nov 2, 2023

    Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine

    Not yet recruiting
    • Influenza, Human
    • ARCT-2138
    • +2 more
    • Brisbane, Queensland, Australia
      Nucleus Network Brisbane Clinic
    Nov 8, 2023

    Pneumococcal Disease Trial in Chengdu (23-valent pneumococcal polysaccharide vaccine, control pneumococcal polysaccharide

    Recruiting
    • Pneumococcal Disease
    • 23-valent pneumococcal polysaccharide vaccine
    • control pneumococcal polysaccharide vaccine
    • Chengdu, Sichuan, China
      Sichuan Center For Disease Control and Prevention
    Sep 19, 2023

    Iron Deficiency Anemia Trial (Iron-fortified cookies, Japanese encephalitis (JE) vaccine, Typhoid Vi polysaccharide (Vi-PS)

    Not yet recruiting
    • Iron Deficiency Anemia
    • Iron-fortified cookies
    • +3 more
    • (no location specified)
    Aug 30, 2023

    Vaccine-Preventable Diseases, Hepatitis B Trial in Seongnam-si (CVI-HBV-002)

    Completed
    • Vaccine-Preventable Diseases
    • Hepatitis B
    • CVI-HBV-002
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      CHA University Bundang Medical Center
    Nov 19, 2023

    SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)

    Recruiting
    • SARS-CoV-2 Infection
    • COVID-19 mRNA Vaccine (ZSVG-02-O)
    • COVID-19 Vaccine (Vero Cell) ,Inactivated
    • Dengfeng, Henan, China
    • +1 more
    Nov 6, 2023

    SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

    Active, not recruiting
    • SARS-CoV-2
    • SARS-CoV-2 mRNA vaccine (RBMRNA)
    • CoronaVac®
    • Chengdu, Sichuan, China
      Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
    Jun 12, 2023

    COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for

    Not yet recruiting
    • COVID-19
    • SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
    • SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
    • Manila, Philippines
    • +2 more
    Jun 21, 2023

    Vaccination; Infection, Vaccine Adverse Reaction Trial (Recombinant zoster vaccination)

    Not yet recruiting
    • Vaccination; Infection
    • Vaccine Adverse Reaction
    • Recombinant zoster vaccination
    • (no location specified)
    Jun 9, 2023

    COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))

    Completed
    • COVID-19
    • Recombinant Novel Coronavirus vaccine (CHO Cells)
    • Changsha, Hunan, China
      Hunan Provincial Center for Disease Control and Prevention
    Jun 6, 2023

    COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))

    Recruiting
    • COVID-19
    • SARS-CoV-2 DNA Vaccine (ICCOV)
    • Wong Chuk Hang, Hong Kong
      Gleneagles Hospital Hong Kong
    Jun 16, 2023

    SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

    Not yet recruiting
    • SARS-CoV-2 Infection
    • +4 more
    • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Municipal Center for Disease Control and Prevention
    Jul 17, 2023

    COVID-19, Vaccine Reaction Trial in Chengdu (LYB001, CoronaVac)

    Active, not recruiting
    • COVID-19
    • Vaccine Reaction
    • LYB001
    • CoronaVac
    • Chengdu, Sichuan, China
      Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
    Jun 29, 2023

    Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

    Not yet recruiting
    • Immunogenicity
    • Safety
    • Phase II:SWIM816;SARS-Cov-2;
    • +3 more
    • (no location specified)
    Jun 18, 2023

    SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

    Not yet recruiting
    • SARS-CoV-2
    • SARS-CoV-2 Bivalent mRNA Vaccine
    • +2 more
    • Nanjing, Jiangsu, China
      Jiangsu Provincial Center for Disease Control and Prevention
    Jul 7, 2023

    Zoster, Systemic Lupus Erythematosus, Vaccine Reaction Trial in Seoul (Shingrix, Placebo)

    Recruiting
    • Zoster
    • +2 more
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Aug 17, 2023

    Epidemic Meningitis Trial (MCV4)

    Not yet recruiting
    • Epidemic Meningitis
    • MCV4
    • (no location specified)
    Jul 5, 2023

    SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

    Not yet recruiting
    • SARS-CoV-2
    • SARS-CoV-2 Bivalent mRNA Vaccine
    • Saline
    • Nanjing, Jiangsu, China
      Jiangsu Provincial Center for Disease Control and Prevention
    Jul 7, 2023